Treatment Options of Asthma in Infancy

Pediatric Pulmonology

Volumn 37, Issue SUPPL. 26, 2004, Pages 20-22

  Bush, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; OXYGEN; GLUCOCORTICOID;

AIRWAY OBSTRUCTION; ASTHMA; ATOPIC DERMATITIS; ATOPY; BRONCHIOLITIS; BRONCHITIS; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC LUNG DISEASE; CHRONIC LUNG DISEASE OF PREMATURITY; COUGHING; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; FACE MASK; HUMAN; INFLAMMATION; INHALATION SPACER; METERED DOSE INHALER; OXYGEN THERAPY; PHENOTYPE; POSTBRONCHIOLITIC COUGH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; TRACHEOMALACIA; VIRUS ASSOCIATED WHEEZE; VIRUS INFECTION; WHEEZING; ABNORMAL RESPIRATORY SOUND; ARTICLE; INFANT; NEBULIZER;

ASTHMA; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; DRUG ADMINISTRATION ROUTES; GLUCOCORTICOIDS; HUMANS; INFANT; NEBULIZERS AND VAPORIZERS; RESPIRATORY SOUNDS;

EID: 1242336922     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.70036     Document Type: Review

References (22)

1. Van Bever HP, Desager KN. Paradoxical bronchoconstriction in wheezing infants after nebulized ipratropium bromide. Br Med J 1990;300:397-8.
2. rendiville A, Rose A, Maxwell DL, Silverman M. Hypoxaemia in wheezy infants after bronchodilator treatment. Arch Dis Child 1987;62:997-1000.
3. Tasche MJA, van der Wouden JC, Uijen JHJM, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4 year old children with moderate asthma. Lancet 1997;350:1060-1064.
4. Tasche MJA, Uijen JHJM, Bersen RMD, et al. Inhaled disodium cromoglycate (DSCG) as maintenance therapy for children with asthma: a systematic review. Thorax 2000;55:913-920.
5. Volovitz B, Welliver J, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24:504-507.
6. Volovitz B, Faden H, Ogra PL. Release of leukotrienes C4 in respiratory tract during acute viral infection. J Pediatr 1988;112:218-222.
7. Warner JO. A double-blind, randomised, placebo-controlled trial of cetrizine in preventing the onset of asthma in children with atopic dermatitis: 18 months treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108:929-937.
8. Wildhaber JH, Devadason SG, Eber E, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996;51:985-8.
9. Chan KN, Wong YC, Silverman M. Relationship between infant lung mechanics and childhood lung function in children of very low birth weight. Pediatr Pulmonol 1990;8:74-81.
10. Lebourges F, Moriette G, Boule M, Delaperche MF, Relier JP, Gaultier C. Pulmonary function in infancy and in childhood following mechanical ventilation in the neonatal period. Pediatr Pulmonol 1990;9:34-40.
11. Chan KN, Noble-Jamieson CM, Elliman A, Bryan EM, Silverman M. Lung function in children of low birth weight. Arch Dis Child 1989;64:1284-93.
12. Parat S, Moriette G, Delaperche M-F, Escourrou P, Denjean A, Gaultier C. Long-term pulmonary function outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol 1995;20:289-96.
13. Hakulinen AL, Jarvenpaa A-L, Turpeinen M, Sovijarvi A. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21:353-60.
14. Pelkonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997;156:1178-84.
15. Ook AJ, Yuksel B, Sampson AP, Greenough A, Price JF. Cysteinyl leukotrienes involvement in chronic lung disease in premature infants. Eur Respir J 1996;9:1907-12.
16. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132:849-853.
17. Welliver RC. The role of RSV IgE in recurrent wheezing and asthma. In: Cloutier MM, ed. RSV and asthma: is there a link? American Thoracic Society, 1998;21-27.
18. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
19. Bisgaard H. A randomised trial of monteleukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383.
20. Bush A, Price JP. Childhood asthma syndromes. In: Gibson GJ, Geddes DM, Costabel U, Sterk P, Corrin B (Eds). Respiratory Medicine. 3rd Edition, Saunders, 2003, pp 1396-1420.
21. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, Jeffery PK. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;167:78-82.
22. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch Dis Child 2001;85:143-148.